This showed an increased frequency and surface level of expression (MFI) of both MT1-MMP and MT5-MMP on CD8+CD20+ T cells compared to CD8+CD20- T cells in patients with early MS. The gene discussed is CD8A; the disease is myeloid sarcoma.